威勝信息(688100.SH):1.5億元對子公司威銘能源進行增資
格隆匯3月19日丨威勝信息(688100.SH)公佈,公司於2020年3月19日召開第一屆董事會第十六次會議和第一屆監事會第九次會議,審議通過了《關於使用部分募集資金和自有資金向全資子公司增資的議案》。
同意公司使用部分募集資金和自有資金共計1.5億元對全資子公司威銘能源進行增資,其中募集資金6294.01萬元用於實施募投項目、自有資金8705.99萬元用於威銘能源主營業務開展,上述增資金額全部計入註冊資本。
此次增資完成後,威銘能源註冊資本由1.5億元變更為3億元,公司仍持有威銘能源100%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.